{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T12:07:26Z","timestamp":1784203646393,"version":"3.55.0"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100010624","name":"Karab\u00fck \u00dcniversitesi","doi-asserted-by":"publisher","award":["BAP-22-ABP-117"],"award-info":[{"award-number":["BAP-22-ABP-117"]}],"id":[{"id":"10.13039\/501100010624","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Microbiological Methods"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.mimet.2026.107551","type":"journal-article","created":{"date-parts":[[2026,5,17]],"date-time":"2026-05-17T14:42:34Z","timestamp":1779028954000},"page":"107551","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Determination of Fosfomycin MIC values in multidrug-resistant Klebsiella pneumoniae isolates and a cost-effective method attempt for routine laboratory testing"],"prefix":"10.1016","volume":"246","author":[{"given":"\u015eerife","family":"Y\u0131lmaz-G\u00fcrb\u00fcz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meryem","family":"Ye\u015fil-\u00c7olak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muharrem","family":"Nasl\u0131","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.mimet.2026.107551_bb0005","doi-asserted-by":"crossref","first-page":"127","DOI":"10.5472\/marumj.942784","article-title":"Determination of Fosfomycin susceptibility in carbapenemaseproducing K. pneumoniae strains isolated prior to clinical use of the intravenous formulation in Turkey","volume":"34","author":"Alt\u0131nkanat Gelmez","year":"2021","journal-title":"Marmara Med. J."},{"key":"10.1016\/j.mimet.2026.107551_bb0010","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/BF02601704","article-title":"Stability of minocycline, doxycycline, and tetracycline stored in agar plates and microdilution trays","volume":"1","author":"Barry","year":"1978","journal-title":"Curr. Microbiol."},{"issue":"1","key":"10.1016\/j.mimet.2026.107551_bb0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.diagmicrobio.2025.117110","article-title":"High in vitro activity of Fosfomycin in carbapenemase-producing Klebsiella pneumoniae and carbapenem-resistant Pseudomonas aeruginosa in clinical isolates in Colombia","volume":"114","author":"Cadena","year":"2026","journal-title":"Diagn. Microbiol. Infect. Dis."},{"issue":"1","key":"10.1016\/j.mimet.2026.107551_bb0020","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.diagmicrobio.2018.07.014","article-title":"Discrepancies in fosfomycin susceptibility testing of KPC-producing Klebsiella pneumoniae with various commercial methods","volume":"93","author":"Camarlinghi","year":"2019","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"10.1016\/j.mimet.2026.107551_bb0025","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.jgar.2020.08.025","article-title":"Gold standard susceptibility testing of fosfomycin in Staphylococcus aureus and Enterobacterales using a new agar dilution panel\u00ae","volume":"23","author":"Campanile","year":"2020","journal-title":"J. Glob. Antimicrob. Resist."},{"key":"10.1016\/j.mimet.2026.107551_bb0030","series-title":"Performance Standards for Antimicrobial Susceptibility Testing; Thirty-Second Informational Supplement","author":"Clinical and Laboratory Standards Institute","year":"2022"},{"issue":"2","key":"10.1016\/j.mimet.2026.107551_bb0040","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.02504-21","article-title":"Fosfomycin susceptibility testing using commercial agar dilution test","volume":"10","author":"Croughs","year":"2022","journal-title":"Microbiol. Spectrum"},{"issue":"4","key":"10.1016\/j.mimet.2026.107551_bb0045","article-title":"Fosfomycin: pharmacological, clinical and future perspectives","volume":"6","author":"Dijkmans","year":"2017","journal-title":"Antibiotics (Basel)"},{"issue":"4","key":"10.1016\/j.mimet.2026.107551_bb0050","doi-asserted-by":"crossref","DOI":"10.1128\/cmr.00008-23","article-title":"Klebsiella pneumoniae carbapenemase variants: the new threat to global public health","volume":"36","author":"Ding","year":"2023","journal-title":"Clin. Microbiol. Rev."},{"issue":"5","key":"10.1016\/j.mimet.2026.107551_bb0055","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1080\/1120009X.2020.1745501","article-title":"In vitro synergistic activity of fosfomycin in combination with meropenem, amikacin and colistin against OXA-48 and\/or NDM-producing Klebsiella pneumoniae","volume":"32","author":"Erturk Sengel","year":"2020","journal-title":"J. Chemother."},{"issue":"9","key":"10.1016\/j.mimet.2026.107551_bb0060","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1046\/j.1469-0691.2000.00142.x","article-title":"EUCAST Definitive Document E.DEF 3.1, June 2000: determination of minimum inhibitory concentrations (MICs) of antibacterial agents by agar dilution","volume":"6","author":"European Committee for Antimicrobial Susceptibility Testing (EUCAST) of the European Society of Clinical Microbiology and Infectious Dieases (ESCMID)","year":"2000","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.mimet.2026.107551_bb0065","author":"European Committee on Antimicrobial Susceptibility Testing (EUCAST)"},{"issue":"2","key":"10.1016\/j.mimet.2026.107551_bb0070","doi-asserted-by":"crossref","first-page":"121","DOI":"10.5578\/mb.202502135","article-title":"Karbapenem diren\u00e7li Klebsiella pneumoniae izolatlar\u0131nda seftazidimavibaktam, fosfomisin ve meropenem\u2019in in vitro sinerjistik etkinli\u011finin ara\u015ft\u0131r\u0131lmas\u0131","volume":"59","author":"G\u00fcneysu Yarar","year":"2025","journal-title":"Mikrobiyol. Bul."},{"issue":"3","key":"10.1016\/j.mimet.2026.107551_bb0075","doi-asserted-by":"crossref","first-page":"213","DOI":"10.5152\/kd.2020.46","article-title":"Fosfomycin: flashback","volume":"33","author":"Haz\u0131rolan","year":"2020","journal-title":"Klimik Derg."},{"issue":"4","key":"10.1016\/j.mimet.2026.107551_bb0080","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.01934-17","article-title":"CLSI methods development and standardization working group best practices for evaluation of antimicrobial susceptibility tests","volume":"56","author":"Humphries","year":"2018","journal-title":"J. Clin. Microbiol."},{"issue":"5","key":"10.1016\/j.mimet.2026.107551_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2023.106763","article-title":"Off-label use versus formal recommendations of conventional and novel antibiotics for the treatment of infections caused by multidrug-resistant bacteria","volume":"61","author":"Jean","year":"2023","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.mimet.2026.107551_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.mimet.2021.106296","article-title":"Rapid detection of fosfomycin resistance in Escherichia coli and Klebsiella spp. strains isolated from urinary tract infections","volume":"188","author":"Kansak","year":"2021","journal-title":"J. Microbiol. Methods"},{"issue":"5","key":"10.1016\/j.mimet.2026.107551_bb0095","doi-asserted-by":"crossref","DOI":"10.3390\/pathogens12050700","article-title":"Reliability of E-tests and the Phoenix automated method in assessing susceptibility to IV fosfomycin\u2014comparative studies relative to the reference method","volume":"12","author":"Kowalska-Krochmal","year":"2023","journal-title":"Pathogens"},{"key":"10.1016\/j.mimet.2026.107551_bb0100","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.jgar.2022.02.018","article-title":"In vitro activity of ceftazidime\/avibactam against gram-negative strains in Colombia 2014-2018","volume":"29","author":"Lemos-Luengas","year":"2022","journal-title":"J. Glob. Antimicrob. Resist."},{"issue":"5","key":"10.1016\/j.mimet.2026.107551_bb0105","doi-asserted-by":"crossref","DOI":"10.3390\/pathogens10050512","article-title":"In vitro susceptibility of multi-drug resistant Klebsiella pneumoniae strains causing nosocomial infections to Fosfomycin. A comparison of determination methods","volume":"10","author":"M\u0105czy\u0144ska","year":"2021","journal-title":"Pathogens"},{"key":"10.1016\/j.mimet.2026.107551_bb0110","doi-asserted-by":"crossref","first-page":"788.e5","DOI":"10.1016\/j.cmi.2020.11.029","article-title":"Evaluation of the commercial AD fosfomycin test for susceptibility testing of multidrug-resistant Enterobacterales and Pseudomonas aeruginosa","volume":"27","author":"Parisio","year":"2020","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.mimet.2026.107551_bb0115","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.ijmmb.2023.01.005","article-title":"Comparison of in vitro fosfomycin susceptibility testing methods with agar dilution for carbapenem resistant Klebsiella pneumoniae and Escherichia coli","volume":"42","author":"Pereira","year":"2023","journal-title":"Indian J. Med. Microbiol."},{"issue":"3","key":"10.1016\/j.mimet.2026.107551_bb0120","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1128\/am.20.3.447-451.1970","article-title":"Stability of antibiotics and chemotherapeutics in agar plates","volume":"20","author":"Ryan","year":"1970","journal-title":"Appl. Microbiol."},{"issue":"4","key":"10.1016\/j.mimet.2026.107551_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.jiac.2025.102643","article-title":"Evaluation of fosfomycin susceptibility testing methods: a focus on multidrug-resistant Klebsiella pneumoniae using ECOFF values","volume":"31","author":"Semerci","year":"2025","journal-title":"J. Infect. Chemother."},{"issue":"4","key":"10.1016\/j.mimet.2026.107551_bb0130","doi-asserted-by":"crossref","first-page":"617","DOI":"10.5578\/mb.20219712","volume":"55","author":"Soydan","year":"2021","journal-title":"Mikrobiyol. Bul."},{"issue":"9","key":"10.1016\/j.mimet.2026.107551_bb0135","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1093\/jac\/dky214","article-title":"Susceptibility of ESBL Escherichia coli and Klebsiella pneumoniae to fosfomycin in the Netherlands and comparison of several testing methods including E test, MIC test strip, Vitek2, Phoenix and disc diffusion","volume":"73","author":"van Den Bijllaardt","year":"2018","journal-title":"J. Antimicrob. Chemother."},{"issue":"4","key":"10.1016\/j.mimet.2026.107551_bb0140","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1080\/1120009X.2021.1963618","article-title":"In-vitro activity of fosfomycin against Escherichia coli and Klebsiella pneumoniae bloodstream isolates and frequency of OXA-48, NDM, KPC, VIM, IMP types of carbapenemases in the carbapenem-resistant groups","volume":"34","author":"Zarakolu","year":"2022","journal-title":"J. Chemother."}],"container-title":["Journal of Microbiological Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167701226001636?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167701226001636?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T11:43:56Z","timestamp":1784202236000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167701226001636"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":27,"alternative-id":["S0167701226001636"],"URL":"https:\/\/doi.org\/10.1016\/j.mimet.2026.107551","relation":{},"ISSN":["0167-7012"],"issn-type":[{"value":"0167-7012","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Determination of Fosfomycin MIC values in multidrug-resistant Klebsiella pneumoniae isolates and a cost-effective method attempt for routine laboratory testing","name":"articletitle","label":"Article Title"},{"value":"Journal of Microbiological Methods","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mimet.2026.107551","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107551"}}